Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1197023014 | Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
1210334010 | Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Is a | Product containing metronidazole in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Is a | Product containing tetracycline in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Has active ingredient | Metronidazole | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Has active ingredient | Tetracycline | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Is a | Product containing bismuth subsalicylate and metronidazole and tetracycline | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Has active ingredient | Bismuth | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Has active ingredient | Bismuth subsalicylate | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Has active ingredient | Antacid | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets